Company / Book Value per Share
Nuvation Bio Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.905
FY2025
5-year range
$0.905 / $3.8K
FY2021-FY2025
Trend
-57.3%
vs FY2024
Sector context
#170 of 209
Health Care
What the data says
Nuvation Bio Inc.'s book value per share of $0.905 is lower than 81% of companies in the Health Care sector (FY2025). Book Value per Share has declined for 4 consecutive years, from $3,769.813 in FY2021 to $0.905 in FY2025.
Based on SEC 10-K filings.
$0.905 in FY2025 with a 5-year CAGR of -16.3%.
Declined from $2,764.629 to $0.905 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -93.3%
- 5-Year CAGR
- -16.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 209This company $0.905 Sector average $189.406
▼
-99.5% below sector average
Key checks
Key Insights
- Nuvation Bio Inc.'s book value per share has declined for 4 consecutive years.
- 5-year CAGR of -16.3%, indicating a declining trend.
- In FY2025, book value per share decreased 57.3% year-over-year.
- Ranks #170 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.905 | -57.3% |
| FY2024 | $2.117 | -99.9% |
| FY2023 | $2.8K | -8.5% |
| FY2022 | $3.0K | -19.8% |
| FY2021 | $3.8K | +170842.5% |
| FY2020 | $2.205 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026